Acting mainly as an anti-inflammatory agent, CecA was able to improve survival after Escherichia coli-induced peritonitis in mice, decreasing the endotoxin and tumor necrosis factor α (TNFα) concentrations in the blood (25). Here, TNF is linked to peritonitis.